乳房病変局在化法市場：タイプ、用途、最終用途別-2025-2030年の世界予測

乳房病変局在化法市場は、2023年に12億米ドルと評価され、2024年には13億9,000万米ドルに達すると予測され、CAGR 15.74％で成長し、2030年には33億6,000万米ドルに達すると予測されています。

乳房病変局在化法市場は、乳房組織の病変を正確に識別してマーキングするために使用される技術やテクノロジーを中心に展開されており、正確な外科的介入と患者の予後改善に不可欠です。このような手法の主な必要性は、生存率と患者のケアを改善するために診断と手術の精度を高めることが要求される乳がんの有病率の増加によってもたらされています。病院、診療所、診断センターで広く応用されている乳房病変の局在診断は、乳房温存手術や術前処置において重要な役割を果たし、患者とヘルスケア提供者の双方に利益をもたらしています。この市場は、効果的で低侵襲な手技に対する需要の高まりに対応する画像誘導定位法やワイヤレス法などの技術的進歩により、大幅な成長の可能性を示しています。主な成長要因としては、がんの早期発見に対する意識の高まり、ヘルスケアインフラの改善、がん研究への多額の資金投入などが挙げられます。しかし、規制上のハードル、先端技術の高コスト、新興国市場でのアクセス制限などの課題が市場開拓の妨げとなる可能性があります。

RFID（無線自動認識）タグや磁気シードによるローカライゼーションのような新しいローカライゼーション技術の研究開発には、最新のビジネスチャンスが存在します。各社は、技術力と市場リーチを拡大するため、戦略的提携やパートナーシップに注力すべきです。低侵襲手技の重視は技術革新の有望分野であり、AIや機械学習技術との統合は早期発見と精度をさらに革新する可能性があります。市場競争は激しいが、製品提供におけるイノベーションと、特に新興市場における地理的プレゼンス拡大は有益であろう。洞察によれば、継続的なイノベーション、規制変更への対応、コスト効率の向上が成功には不可欠です。患者中心のアプローチが普及するにつれ、既存の診断システムとのシームレスな統合を実現する改良型ローカライゼーション技術への需要は、持続的成長を目指す市場プレーヤーにとって引き続き極めて重要です。

市場力学：急速に進化する乳房病変局在化法市場の主要市場インサイトを公開

乳房病変局在化法市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 乳がん罹患率の増加と乳がん手術件数の増加
  • 乳がんの早期発見に対する意識の高まり
  • 乳がん研究に対する政府支出
• 市場抑制要因
  • 規制当局による承認手続きの不確実性
• 市場機会
  • 技術的に高度な乳房局在診断法の採用増加
  • 乳房病変のワイヤレス局在化の出現
• 市場の課題
  • 腫瘍専門医の不足に関する懸念

ポーターの5つの力：乳房病変局在化法市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：乳房病変局在化法市場における外部からの影響の把握

外部マクロ環境要因は、乳房病変局在化法市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析乳房病変局在化法市場における競合情勢の把握

乳房病変局在化法市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス乳房病変局在化法市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、乳房病変局在化法市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨乳房病変局在化法市場における成功への道筋を描く

乳房病変局在化法市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 乳がんの発症率と乳がん手術件数の増加
    • 乳がんの早期発見への意識向上
    • 乳がん調査への政府支出
  • 抑制要因
    • 規制承認手続きの不確実性
  • 機会
    • 技術的に高度なローカリゼーション手順の採用の増加
    • 乳房病変のワイヤレス位置特定技術の登場
  • 課題
    • 腫瘍医不足への懸念
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 乳房病変局在化法市場：タイプ別

• 電磁気的位置特定
• 磁気位置特定
• 放射性同位元素の位置特定
• ワイヤーの位置特定

第7章 乳房病変局在化法市場用途別

• 乳房切除術
• 乳房切除術
• センチネルリンパ節の特定
• 腫瘍の特定

第8章 乳房病変局在化法市場：最終用途別

• 外来診療センター
• 画像診断センター
• 病院

第9章 南北アメリカの乳房病変局在化法市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の乳房病変局在化法市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの乳房病変局在化法市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Argon Medical Devices, Inc.
• Becton, Dickinson and Company
• BIOPSYBELL S.R.L.
• C.P. Medical
• Cianna Medical, Inc.
• Cook Group
• Endomagnetics Limited
• Hologic, Inc.
• ILUMARK GmbH
• Intramedical Imaging
• Intramedical Imaging, LLC
• IsoAid, LLC
• IZI Medical Products by Halma PLC
• Laurane Medical LLC
• Merit Medical Systems, Inc.
• Mermaid Medical
• Molli Surgical Inc.
• Ranfac Corp.
• Sirius Medical System B.V.
• SOMATEX Medical Technologies GmbH by Hologic
• Sterylab S.r.l.
• Stryker Corporation
• Wright Medical Group N.V.

LIST OF FIGURES

• FIGURE 1. BREAST LESION LOCALIZATION METHODS MARKET RESEARCH PROCESS
• FIGURE 2. BREAST LESION LOCALIZATION METHODS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. BREAST LESION LOCALIZATION METHODS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. BREAST LESION LOCALIZATION METHODS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BREAST LESION LOCALIZATION METHODS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. BREAST LESION LOCALIZATION METHODS MARKET DYNAMICS
• TABLE 7. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ELECTROMAGNETIC LOCALIZATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAGNETIC LOCALIZATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIOISOTOPE LOCALIZATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY WIRE LOCALIZATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY LUMPECTOMY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MASTECTOMY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY SENTINEL LYMPH NODE IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TUMOR IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 31. CANADA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 32. CANADA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 33. CANADA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 35. MEXICO BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 36. MEXICO BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 44. ASIA-PACIFIC BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 46. AUSTRALIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 47. AUSTRALIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 48. CHINA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 49. CHINA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 50. CHINA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 51. INDIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 52. INDIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 53. INDIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 55. INDONESIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 56. INDONESIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 58. JAPAN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 59. JAPAN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 61. MALAYSIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 62. MALAYSIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 64. PHILIPPINES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 65. PHILIPPINES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 67. SINGAPORE BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 68. SINGAPORE BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 70. SOUTH KOREA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 71. SOUTH KOREA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 73. TAIWAN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 74. TAIWAN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 76. THAILAND BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 77. THAILAND BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 79. VIETNAM BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 80. VIETNAM BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 84. EUROPE, MIDDLE EAST & AFRICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 86. DENMARK BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 87. DENMARK BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 89. EGYPT BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 90. EGYPT BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 92. FINLAND BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 93. FINLAND BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 95. FRANCE BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 96. FRANCE BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 98. GERMANY BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 99. GERMANY BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 101. ISRAEL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 102. ISRAEL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 103. ITALY BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 104. ITALY BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 105. ITALY BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 107. NETHERLANDS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 108. NETHERLANDS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 110. NIGERIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 111. NIGERIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 113. NORWAY BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 114. NORWAY BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 115. POLAND BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 116. POLAND BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 117. POLAND BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 118. QATAR BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 119. QATAR BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 120. QATAR BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 122. RUSSIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 123. RUSSIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 125. SAUDI ARABIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 126. SAUDI ARABIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH AFRICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH AFRICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 131. SPAIN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 132. SPAIN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 134. SWEDEN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 135. SWEDEN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 137. SWITZERLAND BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 138. SWITZERLAND BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 140. TURKEY BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 141. TURKEY BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 143. UNITED ARAB EMIRATES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 144. UNITED ARAB EMIRATES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 146. UNITED KINGDOM BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 147. UNITED KINGDOM BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 148. BREAST LESION LOCALIZATION METHODS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 149. BREAST LESION LOCALIZATION METHODS MARKET, FPNV POSITIONING MATRIX, 2023

The Breast Lesion Localization Methods Market was valued at USD 1.20 billion in 2023, expected to reach USD 1.39 billion in 2024, and is projected to grow at a CAGR of 15.74%, to USD 3.36 billion by 2030.

The Breast Lesion Localization Methods market revolves around the techniques and technologies used to accurately identify and mark lesions in breast tissue, crucial for precise surgical interventions and better patient outcomes. The primary necessity for these methods is driven by the increasing prevalence of breast cancer, which demands enhanced diagnostic and surgical precision to improve survival rates and patient care. Widely applied in hospitals, clinics, and diagnostic centers, breast lesion localization plays a critical role in breast-conserving surgeries and pre-operative procedures, benefiting both patients and healthcare providers. The market demonstrates substantial growth potential due to technological advancements such as image-guided localization and wireless methods, addressing the rising demand for effective and minimally invasive techniques. Key growth influencers include the increasing awareness of early cancer detection, improved healthcare infrastructure, and significant funding in cancer research. However, challenges such as regulatory hurdles, high costs of advanced technology, and limited accessibility in developing regions can hinder market growth.

Latest opportunities exist in the R&D of novel localization techniques like radiofrequency identification (RFID) tags and magnetic seed localization, which promise enhanced accuracy and patient comfort. Companies should focus on strategic collaborations and partnerships to expand their technological capabilities and market reach. The emphasis on minimally invasive procedures presents a promising area for innovation, while integration with AI and machine learning technologies may further revolutionize early detection and precision. Although the market is highly competitive, innovations in product offerings and expanding geographical presence, especially in emerging markets, could be beneficial. Insights show that continuous innovation, keeping pace with regulatory changes, and enhancing cost-efficiency will be vital for success. As patient-centric approaches gain traction, the demand for improved localization technologies that provide seamless integration with existing diagnostic systems remains pivotal for market players aiming towards sustainable growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Breast Lesion Localization Methods Market

The Breast Lesion Localization Methods Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing incidence of breast cancer and increasing number of breast cancer surgeries
  • Increasing awareness on the early detection of breast cancer
  • Government spending on breast cancer research
• Market Restraints
  • Uncertainty in regulatory approval procedures
• Market Opportunities
  • Increasing adoption of technologically advanced localization procedures
  • Emergence of wireless localization of breast lesion
• Market Challenges
  • Concerns regarding the shortage of oncologists

Porter's Five Forces: A Strategic Tool for Navigating the Breast Lesion Localization Methods Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Breast Lesion Localization Methods Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Breast Lesion Localization Methods Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Breast Lesion Localization Methods Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Breast Lesion Localization Methods Market

A detailed market share analysis in the Breast Lesion Localization Methods Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Breast Lesion Localization Methods Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Breast Lesion Localization Methods Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Breast Lesion Localization Methods Market

A strategic analysis of the Breast Lesion Localization Methods Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Breast Lesion Localization Methods Market, highlighting leading vendors and their innovative profiles. These include Argon Medical Devices, Inc., Becton, Dickinson and Company, BIOPSYBELL S.R.L., C.P. Medical, Cianna Medical, Inc., Cook Group, Endomagnetics Limited, Hologic, Inc., ILUMARK GmbH, Intramedical Imaging, Intramedical Imaging, LLC, IsoAid, LLC, IZI Medical Products by Halma PLC, Laurane Medical LLC, Merit Medical Systems, Inc., Mermaid Medical, Molli Surgical Inc., Ranfac Corp., Sirius Medical System B.V., SOMATEX Medical Technologies GmbH by Hologic, Sterylab S.r.l., Stryker Corporation, and Wright Medical Group N.V..

Market Segmentation & Coverage

This research report categorizes the Breast Lesion Localization Methods Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Electromagnetic Localization, Magnetic Localization, Radioisotope Localization, and Wire Localization.
• Based on Usage, market is studied across Lumpectomy, Mastectomy, Sentinel Lymph Node Identification, and Tumor Identification.
• Based on End-Use, market is studied across Ambulatory Care Centers, Diagnostic Imaging Centers, and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing incidence of breast cancer and increasing number of breast cancer surgeries
    • 5.1.1.2. Increasing awareness on the early detection of breast cancer
    • 5.1.1.3. Government spending on breast cancer research
  • 5.1.2. Restraints
    • 5.1.2.1. Uncertainty in regulatory approval procedures
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing adoption of technologically advanced localization procedures
    • 5.1.3.2. Emergence of wireless localization of breast lesion
  • 5.1.4. Challenges
    • 5.1.4.1. Concerns regarding the shortage of oncologists
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Breast Lesion Localization Methods Market, by Type

• 6.1. Introduction
• 6.2. Electromagnetic Localization
• 6.3. Magnetic Localization
• 6.4. Radioisotope Localization
• 6.5. Wire Localization

7. Breast Lesion Localization Methods Market, by Usage

• 7.1. Introduction
• 7.2. Lumpectomy
• 7.3. Mastectomy
• 7.4. Sentinel Lymph Node Identification
• 7.5. Tumor Identification

8. Breast Lesion Localization Methods Market, by End-Use

• 8.1. Introduction
• 8.2. Ambulatory Care Centers
• 8.3. Diagnostic Imaging Centers
• 8.4. Hospitals

9. Americas Breast Lesion Localization Methods Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Breast Lesion Localization Methods Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Breast Lesion Localization Methods Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Argon Medical Devices, Inc.
• 2. Becton, Dickinson and Company
• 3. BIOPSYBELL S.R.L.
• 4. C.P. Medical
• 5. Cianna Medical, Inc.
• 6. Cook Group
• 7. Endomagnetics Limited
• 8. Hologic, Inc.
• 9. ILUMARK GmbH
• 10. Intramedical Imaging
• 11. Intramedical Imaging, LLC
• 12. IsoAid, LLC
• 13. IZI Medical Products by Halma PLC
• 14. Laurane Medical LLC
• 15. Merit Medical Systems, Inc.
• 16. Mermaid Medical
• 17. Molli Surgical Inc.
• 18. Ranfac Corp.
• 19. Sirius Medical System B.V.
• 20. SOMATEX Medical Technologies GmbH by Hologic
• 21. Sterylab S.r.l.
• 22. Stryker Corporation
• 23. Wright Medical Group N.V.